JP2014202535A
|
|
Serological diagnosis method for pertussis
|
EP2743699A1
|
|
Method for testing for, preventing, and treating infectious disease aspergillus fumigatus, and composition
|
JP2013166699A
|
|
Composite body containing inactivated virus particle and use thereof
|
JP2010017144A
|
|
Method for detecting bacterium of genus legionella, and detection kit
|
JP2009005589A
|
|
Method for inactivating hepatitis c virus with uv
|
JP2006300629A
|
|
Penetration testing method of protective clothing material and penetration tester
|
JP2006252099A
|
|
Bio-security system
|
JP2006238724A
|
|
Method for designing rna interference polynucleotide mixture, device for designing rna interference polynucleotide mixture, method for producing rna interference polynucleotide mixture, program for designing rna interference polynucleotide mixture and rna interference polynucleotide mixture
|
JP2006191891A
|
|
Attenuated hiv-1 base sequence
|
US2005266066A1
|
|
Phospholipid membrane preparation
|
JP2005239576A
|
|
Inhibition of salmonella disease-causing gene expression with 1,2-propanediol
|
JP2003144168A
|
|
Cell cycle-relating protein having nuclear export function or nucleus-cytoplasm transport function
|
JP2003116565A
|
|
Monoclonal antibody recognizing crimean-congo hemorrhagic fever virus
|
JP2002191399A
|
|
Method for assaying drug resistance of hiv
|
JP2003061667A
|
|
Gene of new antigen of corynebacterium diphtheriae
|
JP2003034650A
|
|
Agent for preventing intestinal infectious disease and food-and-drink containing the same
|
JP2003009874A
|
|
Dna encoding infectious hiv genome
|
JP2002306164A
|
|
Monoclonal antibody recognizing ebola virus
|
JP2002262880A
|
|
Ribozyme-expressing system
|
JP2002159297A
|
|
Method for assaying protease activity
|